‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

A request by CRISPR scientists to withdraw their patents over allegations of mishandling by the EPO’s Boards of Appeals has thrust a ‘fundamentally unfair, uncertain system’ into sharp focus, finds Sarah Speight.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Huawei wins seven-country ban on Netgear routers at the UPC

Propel Fuels seeks top-up damages of $1.2bn in secrets case

Leading US trademark firms and lawyers recognised in new national rankings

Lenovo faces US import ban as ITC sides with Ericsson

Samsara v Motive: ‘Secrets case reads like a pulp novel’

USPTO sanctions attorney over sham Chinese TM filings

‘We want passion, fun and noise’: Ocado’s Lucy Wojcik on stress testing counsel

Arusha Protocol takes root: Fresh growth for plant variety protection in Africa

‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

More on this story

Editor's picks

Editor's picks

More articles